Abstract:The poor prognosis of patients with osteosarcoma remains a persistent problem, in particular for patients with unresectable tumors or metastasis. Therefore, combination of radiotherapy and chemotherapy has been considered for patients with metastasis or recurrence, patients unsuitable for surgery and patients refusing surgery. The present study aimed to investigate the effect of the combined treatment with cisplatin and radiation therapy on the biological characteristics of the osteosarcoma cell line MG-63 and the breast cancer 1 (BRCA1)-associated signaling pathways. Cell proliferation was determined using Cell Counting kit-8 assay, and cell apoptosis and cell cycle were assessed by flow cytometry. Cell migration was examined by Transwell assay. The mRNA and protein expression levels of candidate genes, including BRCA1 and p53, were determined by reverse transcription-quantitative PCR and western blotting, respectively. The results demonstrated that combined treatment with radiation and cisplatin significantly inhibited MG-63 cell proliferation compared with radiation or cisplatin treatment alone. Furthermore, radiation, cisplatin or the combined treatment with radiation and cisplatin increased the apoptosis rate of MG-63 cells, which resulted in G2 phase arrest, and significantly decreased the migratory capacity of MG-63 cells. In addition, the apoptosis rate of MG-63 cells following combined radiation and cisplatin treatment was higher compared with the cisplatin group, but lower compared with the radiation group. Furthermore, combined treatment with radiation and cisplatin decreased the mRNA and protein expression levels of BRCA1 and p53. Additionally, combined treatment with radiation and cisplatin had a more potent inhibitory effect on p53 expression than on BRCA1 expression. In addition, combination of radiation and cisplatin had a higher inhibitory effect on Bax protein level and a higher inductive effect on Bcl-2 protein level compared with treatments with radiation and cisplatin alone. The results demonstrated that combined treatment of radiation and cisplatin exhibited superior therapeutic effects on osteosarcoma MG-63 cells compared with radiation or cisplatin treatment alone, which may be mediated by the BRCA1-p53 signaling pathway.

Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.

Checkpoint Kinase Inhibitor AZD7762 Enhance Cisplatin-Induced Apoptosis in Osteosarcoma Cells.

Synergistic Apoptotic Effect of Crocin and Cisplatin on Osteosarcoma Cells Via Caspase Induced Apoptosis.

Valproic Acid Combined with Zoledronate Enhance Γδ T Cell-Mediated Cytotoxicity Against Osteosarcoma Cells Via the Accumulation of Mevalonate Pathway Intermediates.

Pharmacological Ascorbate Induces Osteosarcoma&nbsp;Cells Death via H2O2&nbsp;Mediated-Oxidative Stress&nbsp;and Enhances the Efficacy of Cisplatin in Osteosarcoma

Celecoxib Enhances Anticancer Effect of Cisplatin and Induces Anoikis in Osteosarcoma Via PI3K/Akt Pathway.

Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells

Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma

Bortezomib Sensitizes Human Osteosarcoma Cells to Adriamycin‐induced Apoptosis Through ROS‐dependent Activation of P‐eif2α/atf4/chop Axis

Sensitization of Human Osteosarcoma Cells to Vγ9Vδ2 T‐cell‐mediated Cytotoxicity by Zoledronate

Zoledronic acid induces ferroptosis by upregulating POR in osteosarcoma

Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway

Suppression of Osteosarcoma Cells Growth by 3-Aminobenzamide Combined with Cisplatin

Synergistic Inhibitory Activity of Zoledronic Acid and Paclitaxel on Bone Metastasis in Nude Mice

Combined effects of zoledronic acid with doxorubicin against human osteosarcoma xenograft model in nude mice

Effect of Zoledronic Acid on Proliferation, Apoptosis and Expression of VEGF of Osteosarcoma Cell Line LM8

Hypoxia Inhibitor Combined with Chemotherapeutic Agents for Antitumor and Antimetastatic Efficacy against Osteosarcoma

The Apoptotic Effect of Zoledronic Acid on the Nasopharyngeal Carcinoma Cells Via ROS Mediated Chloride Channel Activation

The Inhibitory Effects of Cisplatin-Radiation Combination Treatment on Malignant Osteosarcoma MG-63 Cells and BRCA1-p53 Pathways Are More Efficient Than Single Treatments.

Synergistic Effect of Docetaxel Combined with Cisplatin on Inhibiting Human Osteosarcoma in Nude Mice

The Synergistic Reducing Drug Resistance Effect of Cisplatin and Ursolic Acid on Osteosarcoma through a Multistep Mechanism Involving Ferritinophagy